These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 8465823

  • 1. Determinants of oxalate balance in patients on chronic peritoneal dialysis.
    Marangella M, Bagnis C, Bruno M, Petrarulo M, Gabella P, Linari F.
    Am J Kidney Dis; 1993 Apr; 21(4):419-26. PubMed ID: 8465823
    [Abstract] [Full Text] [Related]

  • 2. Oxalate dynamics and removal rates during haemodialysis and peritoneal dialysis in patients with primary hyperoxaluria and severe renal failure.
    Watts RW, Veall N, Purkiss P.
    Clin Sci (Lond); 1984 May; 66(5):591-7. PubMed ID: 6368103
    [Abstract] [Full Text] [Related]

  • 3. Plasma concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Yamauchi A, Fujii M, Shirai D, Mikami H, Okada A, Imai E, Ando A, Orita Y, Kamada T.
    Clin Nephrol; 1986 Apr; 25(4):181-5. PubMed ID: 3698351
    [Abstract] [Full Text] [Related]

  • 4. [Kinetics of oxalate in hemodialysis].
    Marangella M, Petrarulo M, Vitale C, Cosseddu D, Linari F.
    Minerva Urol Nefrol; 1991 Apr; 43(3):165-9. PubMed ID: 1817340
    [Abstract] [Full Text] [Related]

  • 5. Effects of ascorbic acid and pyridoxine supplementation on oxalate metabolism in peritoneal dialysis patients.
    Shah GM, Ross EA, Sabo A, Pichon M, Reynolds RD, Bhagavan H.
    Am J Kidney Dis; 1992 Jul; 20(1):42-9. PubMed ID: 1621677
    [Abstract] [Full Text] [Related]

  • 6. Plasma oxalate levels rise in hemodialysis patients despite increased oxalate removal.
    Costello JF, Sadovnic MJ, Cottington EM.
    J Am Soc Nephrol; 1991 Jun; 1(12):1289-98. PubMed ID: 1912391
    [Abstract] [Full Text] [Related]

  • 7. Plasma oxalate in patients with chronic renal failure receiving continuous ambulatory peritoneal dialysis or hemodialysis.
    McConnell KN, Rolton HA, Modi KS, Macdougall AI.
    Am J Kidney Dis; 1991 Oct; 18(4):441-5. PubMed ID: 1928062
    [Abstract] [Full Text] [Related]

  • 8. Oxalate elimination via hemodialysis or peritoneal dialysis in children with chronic renal failure.
    Hoppe B, Graf D, Offner G, Latta K, Byrd DJ, Michalk D, Brodehl J.
    Pediatr Nephrol; 1996 Aug; 10(4):488-92. PubMed ID: 8865249
    [Abstract] [Full Text] [Related]

  • 9. Oxalate Balance in Peritoneal Dialysis Patients: A Potential Role of Dialysis-related Peritonitis.
    Stepanova N, Korol L, Lebid L, Snisar L, Savchenko S.
    In Vivo; 2022 Aug; 36(2):925-933. PubMed ID: 35241551
    [Abstract] [Full Text] [Related]

  • 10. Plasma level and renal clearance of oxalate in normal subjects and in patients with primary hyperoxaluria or chronic renal failure or both.
    Constable AR, Joekes AM, Kasidas GP, O'Regan P, Rose GA.
    Clin Sci (Lond); 1979 Apr; 56(4):299-304. PubMed ID: 477214
    [Abstract] [Full Text] [Related]

  • 11. The prescription of peritoneal dialysis.
    Tzamaloukas AH, Raj DS, Onime A, Servilla KS, Vanderjagt DJ, Murata GH.
    Semin Dial; 2008 Apr; 21(3):250-7. PubMed ID: 18248525
    [Abstract] [Full Text] [Related]

  • 12. Plasma profiles and dialysis kinetics of oxalate in patients receiving hemodialysis.
    Marangella M, Petrarulo M, Mandolfo S, Vitale C, Cosseddu D, Linari F.
    Nephron; 1992 Apr; 60(1):74-80. PubMed ID: 1738418
    [Abstract] [Full Text] [Related]

  • 13. Renal excretion of oxalate in patients with chronic renal failure or nephrolithiasis.
    Chen SM, Chen TW, Lee YH, Chu WY, Young TK.
    J Formos Med Assoc; 1990 Aug; 89(8):651-6. PubMed ID: 1981225
    [Abstract] [Full Text] [Related]

  • 14. Hyperoxalemia in renal failure and the role of hemoperfusion and hemodialysis in primary oxalosis.
    Ahmad S, Hatch M.
    Nephron; 1985 Aug; 41(3):235-40. PubMed ID: 4058624
    [Abstract] [Full Text] [Related]

  • 15. Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure.
    Worcester EM, Nakagawa Y, Bushinsky DA, Coe FL.
    J Clin Invest; 1986 Jun; 77(6):1888-96. PubMed ID: 3711339
    [Abstract] [Full Text] [Related]

  • 16. Effect of pyridoxine supplementation on plasma oxalate concentrations in patients receiving dialysis.
    Tomson CR, Channon SM, Parkinson IS, Sheldon WS, Ward MK, Laker MK.
    Eur J Clin Invest; 1989 Apr; 19(2):201-5. PubMed ID: 2499479
    [Abstract] [Full Text] [Related]

  • 17. Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure.
    Hoppe B, Kemper MJ, Bökenkamp A, Portale AA, Cohn RA, Langman CB.
    Kidney Int; 1999 Jul; 56(1):268-74. PubMed ID: 10411702
    [Abstract] [Full Text] [Related]

  • 18. Effect of vitamin B6 supplementation on plasma oxalate and oxalate removal rate in hemodialysis patients.
    Costello JF, Sadovnic MC, Smith M, Stolarski C.
    J Am Soc Nephrol; 1992 Oct; 3(4):1018-24. PubMed ID: 1450364
    [Abstract] [Full Text] [Related]

  • 19. Oxalate balance studies in patients on hemodialysis for type I primary hyperoxaluria.
    Marangella M, Petrarulo M, Cosseddu D, Vitale C, Linari F.
    Am J Kidney Dis; 1992 Jun; 19(6):546-53. PubMed ID: 1595703
    [Abstract] [Full Text] [Related]

  • 20. Oxalate metabolism in end-stage renal disease: the effect of ascorbic acid and pyridoxine.
    Morgan SH, Maher ER, Purkiss P, Watts RW, Curtis JR.
    Nephrol Dial Transplant; 1988 Jun; 3(1):28-32. PubMed ID: 3132636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.